Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-year analysis of susceptibilities of Candida Species to fluconazole and voriconazole as determined by CLSI standardized disk diffusion.
about
Adoptive T-cell therapy for fungal infections in haematology patientsEpidemiology and risk factors for invasive candidiasisThe potential impact of antifungal drug resistance mechanisms on the host immune response to CandidaCandida parapsilosis is a significant neonatal pathogen: a systematic review and meta-analysisSystematic phenotyping of a large-scale Candida glabrata deletion collection reveals novel antifungal tolerance genesThe widely used ATB FUNGUS 3 automated readings in China and its misleading high MICs of Candida spp. to azoles: challenges for developing countries' clinical microbiology labsNational surveillance of fungemia in Denmark (2004 to 2009)Activity of crude extracts from Brazilian cerrado plants against clinically relevant Candida speciesResistance Mechanisms and Clinical Features of Fluconazole-Nonsusceptible Candida tropicalis Isolates Compared with Fluconazole-Less-Susceptible IsolatesReliable differentiation of Meyerozyma guilliermondii from Meyerozyma caribbica by internal transcribed spacer restriction fingerprinting.Surveillance of the prevalence, antibiotic susceptibility, and genotypic characterization of invasive candidiasis in a teaching hospital in China between 2006 to 2011.Regional data analysis of Candida non-albicans strains collected in United States medical sites over a 6-year period, 2006-2011.Epidemiology and outcomes of invasive candidiasis due to non-albicans species of Candida in 2,496 patients: data from the Prospective Antifungal Therapy (PATH) registry 2004-2008.Glutathione utilization by Candida albicans requires a functional glutathione degradation (DUG) pathway and OPT7, an unusual member of the oligopeptide transporter family.Surveillance of Candida spp bloodstream infections: epidemiological trends and risk factors of death in two Mexican tertiary care hospitalsEpidemiology, species distribution and outcome of nosocomial Candida spp. bloodstream infection in ShanghaiMolecular epidemiology and azole resistance mechanism study of Candida guilliermondii from a Chinese surveillance system.Establishment of an in vitro system to study intracellular behavior of Candida glabrata in human THP-1 macrophagesCandida palmioleophila: characterization of a previously overlooked pathogen and its unique susceptibility profile in comparison with five related species.Modulation of histone H3 lysine 56 acetylation as an antifungal therapeutic strategyYeast identification: reassessment of assimilation tests as sole universal identifiers.Local silencing controls the oxidative stress response and the multidrug resistance in Candida glabrata.Role of FKS Mutations in Candida glabrata: MIC values, echinocandin resistance, and multidrug resistance.Susceptibility of Candida species and various moulds to antimycotic drugs: use of epidemiological cutoff values according to EUCAST and CLSI in an 8-year survey.Candidiasis caused by Candida kefyr in a neonate: case report.Molecular identification and antifungal susceptibility testing of clinical isolates of the Candida rugosa species complex and proposal of the new species Candida neorugosa.Species identification and antifungal susceptibility testing of Candida bloodstream isolates from population-based surveillance studies in two U.S. cities from 2008 to 2011.Functional genomic analysis of Candida glabrata-macrophage interaction: role of chromatin remodeling in virulence.Candida guilliermondii and other species of candida misidentified as Candida famata: assessment by vitek 2, DNA sequencing analysis, and matrix-assisted laser desorption ionization-time of flight mass spectrometry in two global antifungal surveillanRoutine identification and mixed species detection in 6,192 clinical yeast isolates.Clinical hepatotoxicity associated with antifungal agents.Advances in identification of clinical yeast isolates by use of matrix-assisted laser desorption ionization-time of flight mass spectrometry.Intravenous anidulafungin followed optionally by oral voriconazole for the treatment of candidemia in Asian patients: results from an open-label Phase III trialEmerging and emerged pathogenic Candida species: beyond the Candida albicans paradigmEpidemiology of invasive fungal infections in the mediterranean areaDevelopment of two molecular approaches for differentiation of clinically relevant yeast species closely related to Candida guilliermondii and Candida famata.Comparison of in vitro susceptibility characteristics of Candida species from cases of invasive candidiasis in solid organ and stem cell transplant recipients: Transplant-Associated Infections Surveillance Network (TRANSNET), 2001 to 2006Genome-wide survey of transcriptional initiation in the pathogenic fungus, Candida glabrata.Species distribution and susceptibility profile to fluconazole, voriconazole and MXP-4509 of 551 clinical yeast isolates from a Romanian multi-centre study.Efficacy of oral E1210, a new broad-spectrum antifungal with a novel mechanism of action, in murine models of candidiasis, aspergillosis, and fusariosis.
P2860
Q26781064-A6D4D1A6-8DB4-4C23-8EB0-32155B7B1013Q27024911-9A11A30B-788E-400F-AB0F-D3D2FAFD3F4CQ27026751-CA55E2BF-0FFB-4034-AD5D-215ADC3DDCF4Q28533912-95040D8E-8553-4E51-B401-92669C50F55DQ28539874-0FF7D292-9F33-4FDA-B6CB-6A28C11CC12DQ28542429-2180496D-7AA1-4BE5-9546-6C615119F396Q28743556-99D07D4D-1152-4FE1-BF6D-1EF9556AC428Q28830609-E068A202-EF66-4AC7-8292-31C231704D22Q28833536-0E0E8A3D-71A7-460F-A7AA-007F64B7B331Q30392109-DF408F35-79DB-4DB0-8112-27958D13566EQ30658189-0F1EC02F-B851-4906-8B02-626251F3B033Q30826889-26EE7C45-DDA9-421D-A9CA-9E4654457DB6Q30834974-AFD6377A-E0A1-47E9-BA9D-32460D379C17Q31034172-38F76F35-8D9B-4988-9130-CFD2B283EBFEQ33618418-C168644C-7CDD-40DB-A95C-6A730CD2D700Q33661367-4EFFF70C-CA56-4B9E-BBDC-E4B4236EE1E6Q33680814-464DF39B-44F7-4BDF-ADB4-E332A9D53F72Q33720389-4FAD8F5C-B8CF-4379-9F18-6490C8B09206Q33767746-A69DD5BA-4A9F-4D3E-BD2A-001CAD65DA20Q33940382-9548C7A2-7A41-40FA-88FB-7E1B952C5296Q33975405-146B6468-1C75-4AA5-9593-1361DAF83840Q34036604-F4A2691A-9359-42B3-90F4-4C0633A58F0DQ34058099-0EF3EF01-2158-4CD1-B9A7-C00F738E3CC6Q34187936-9E6D9AC4-11DE-4A87-BC51-81E97C8A866BQ34198136-9B3F6207-14F6-461E-A807-B72393620595Q34254380-123838B4-56A4-4B7C-B1EC-1FFDE4702263Q34372192-FC2BA41F-29C3-4B35-83CE-83BD49109012Q34390528-8752EB7F-1980-42A4-A8B1-6869A33E391CQ34458142-82E8C540-5900-49BF-AD16-A2717506FDA0Q34503341-BF88D6B8-4D28-4BEE-8FD3-CB89D0B400B5Q34546811-AA31B7C6-774B-48A6-8383-ADDBCF50330DQ34593760-45AE8500-5BC3-48C9-BE44-F0A7890174FAQ34724039-39BA9450-A6E6-432F-9629-37B5B31EA7CAQ35004446-1833EFFB-530C-4318-8AC4-F77904B968A6Q35010686-82A11031-CFA3-42F9-9EF7-47AB42E57FE0Q35035707-A3F62281-FFCC-4C82-8DA1-96D77B075700Q35140151-544D1A68-AFC2-4ADF-BEDA-4D73A75B6B21Q35145957-9A002121-C8AA-410A-B4A2-68B1B60DEE70Q35254046-A1B86691-938B-43F5-90FD-B00D8992E2BEQ35270948-7CD7FBD5-4FC9-4D96-A8E5-20093A75767D
P2860
Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-year analysis of susceptibilities of Candida Species to fluconazole and voriconazole as determined by CLSI standardized disk diffusion.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Results from the ARTEMIS DISK ...... I standardized disk diffusion.
@en
Results from the ARTEMIS DISK ...... I standardized disk diffusion.
@nl
type
label
Results from the ARTEMIS DISK ...... I standardized disk diffusion.
@en
Results from the ARTEMIS DISK ...... I standardized disk diffusion.
@nl
prefLabel
Results from the ARTEMIS DISK ...... I standardized disk diffusion.
@en
Results from the ARTEMIS DISK ...... I standardized disk diffusion.
@nl
P2093
P2860
P356
P1476
Results from the ARTEMIS DISK ...... SI standardized disk diffusion
@en
P2093
Global Antifungal Surveillance Group
M A Pfaller
V A Newell
P2860
P304
P356
10.1128/JCM.02117-09
P407
P577
2010-02-17T00:00:00Z